VICL (Vical Labs) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Bogdanoff who wrote (247)	5/18/1997 5:06:00 PM
From: William Strop	of 1972

Dave, The 'delivery system' is covered in the two patents Vical was issued in 12/96 & 1/97. These patents cover the Company's technology for direct intramuscular injection of "naked" DNA sequences (genes) to cause production of specific proteins intended to prevent or treat diseases. No portion of a virus is required to effectively transfer DNA into living cells. IMO, this 'delivery system' would be used regardless of what company developed a treatment or vaccine for a certain condition. The Allovectin-7 trials may show some promising use for melanoma treatment, but to me also show promising use of the entire process including the delivery. I am not qualified to say whether this form of treatment will ever be totally successful, but if it is, there will probably be a need to 'deliver' many treatments to cells. So, who ya gonna call --- I hope Vical.. BTW, an investor packet from Vical, may contain a lot of background. I got one a few years back & am on the mailing list both of which help me to understand the concept in general. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next